Trial intelligence / Profile preview

Intravenous tranexamic acid for perioperative blood loss in spinal metastasis decompressive surgery

TCTR20240608003Phase 4Recruiting

Sponsor
Department of Orthopaedic Surgery, Siriraj Hospital
Start
Mar 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tranexamic acid in cancer, sponsored by Department of Orthopaedic Surgery, Siriraj Hospital. Started Mar 2024; status: recruiting.

02

Drugs

tranexamic acid
03

Conditions

cancer

Beyond the preview

Go deeper on TCTR20240608003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20240608003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call